According to the research report titled ‘U.S. Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, U.S. direct-to-consumer (DTC) genetic testing market is expected to cross USD 850 million by the year 2025.
 

Growing occurrence of genetic disorders such as Alzheimer’s, Parkinson’s, and achondroplasia is the major factor driving U.S. DTC genetic testing market growth. Increasing consumer awareness regarding availability of DTC genetic testing devices is also aiding the expansion of market. DTC genetic testing devices help to recognize genetic alterations and probability of encountering genetic ailments which further reduces the mortality rates.
 

Increasing R&D activities have compelled key industry players to develop innovative solutions which has led to rising adoption of DTC genetic testing devices across the United States. Availability of personalized testing kits, in consort with accuracy and user-friendly operability of devices will augment the market demand. However, high cost of such kits may hinder the growth of the market.
 

As per test type, predictive testing segment is expected to grow with a CAGR of 16% during the period of 2019-2025. Predictive testing aids in identifying the disease before its onset which further facilitates in minimizing mortality and morbidity rates.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2276199/
 

In terms of technology, SNP (single nucleotide polymorphism) chip segment was worth USD 140 million in 2018 and will register continuous growth during the estimated timeframe. SNP chips help in evaluating gene sequences in a specific resolution and in less time. These chips analyze the disease at molecular level which further enhances the efficiency of the test. Thus, rising adoption of SNP chips for drug discovery procedures is fueling the growth of the segment.
 

The prominent companies operating in U.S. DTC genetic testing market are Genesis Healthcare, Pathway Genomics, Full Genome, Easy DNA, FamilytreeDNA, 23andME, Color Genomics, and Ancestry among others.